Renal cell carcinoma in children and young adults: Clinicopathological, immunohistochemical, and VHL gene analysis of 46 cases with follow-up

International Journal of Surgical Pathology

Volumn 19, Issue 2, 2011, Pages 170-179

  Rao, Qiu ^a   Chen, Jie Yu ^b   Wang, Jian Dong ^a   Ma, Heng Hui ^a   Zhou, Hang Bo ^a   Lu, Zhen Feng ^a   Zhou, Xiao Jun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

pediatric renal cell carcinoma; prognosis; TFE3; VHL gene analysis; Xp11.2 translocation carcinomas

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE DELETION; GENE MUTATION; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GERMLINE MICRONUCLEUS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MALE; MORPHOLOGY; OUTCOME ASSESSMENT; PATHOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA SPLICING; SCHOOL CHILD; KIDNEY TUMOR; MUTATION; VON HIPPEL LINDAU DISEASE; YOUNG ADULT;

ADULT; CARCINOMA, RENAL CELL; CHILD; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MUTATION; TRANSLOCATION, GENETIC; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 79953873304     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896909354337     Document Type: Article

References (24)

1. Cook A., Lorenzo AJ, Salle JL, et al. Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. J Urol. 2006 ; 175: 1456-1460.
2. Bodmer D., van den Hurk W., van Groningen JJ, et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet. 2002 ; 11: 2489-2498. (Pubitemid 35174713)
3. van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA, et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. BMC Cancer. 2005 ; 5: 57.
4. Parast MM, Eudy G., Gow KW, Amin M., Shehata B. A unique case of renal carcinoma with Xp11.2 translocations/ TFE3 gene fusions in a 3-year-old child, with coexistent von Hippel-Lindau gene mutation. Pediatr Dev Pathol. 2004 ; 7: 403-406. (Pubitemid 39145715)
5. Argani P. The evolving story of renal translocation carcinomas. Am J Clin Pathol. 2006 ; 126: 332-334. (Pubitemid 44338783)
6. Argani P., Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001 ; 159: 179-192. (Pubitemid 33704203)
7. Argani P., Antonescu CR, Couturier J., et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002 ; 26: 1553-1566. (Pubitemid 35387219)
8. Argani P., Laé M., Hutchinson B., et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005 ; 29: 230-240. (Pubitemid 40170642)
9. Argani P., Lal P., Hutchinson B., Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003 ; 27: 750-761. (Pubitemid 36617511)
10. Lopez-Beltran A., Scarpelli M., Montironi R., Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006 ; 49: 798-805.
11. Argani P., Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005 ; 25: 363-378. (Pubitemid 40545824)
12. Rao Q., Zhou XJ, Wu B., et al. Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: a study of 11 cases and review of literature [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2007 ; 36: 244-246. (Pubitemid 46841815)
13. Crossey PA, Maher ER, Jones MH, et al. Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum Mol Genet. 1993 ; 2: 279-282. (Pubitemid 23129088)
14. Argani P., Olgac S., Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007 ; 31: 1149-1160. (Pubitemid 47207116)
15. Bruder E., Passera O., Harms D., et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004 ; 28: 1117-1132. (Pubitemid 39121606)
16. Wu A., Kunju LP, Cheng L., Shah RB Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation- associated and unusual clear cell subtypes. Histopathology. 2008 ; 53: 533-544.
17. Ma X., Yang K., Lindblad P., Egevad L., Hemminki K. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium. Oncogene. 2001 ; 20: 5393-5400. (Pubitemid 32844071)
18. Ramphal R., Pappo A., Zielenska M., Grant R., Ngan BY Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol. 2006 ; 126: 349-364. (Pubitemid 44338787)
19. Argani P., Lui MY, Couturier J., Bouvier R., Fournet JC, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003 ; 22: 5374-5378. (Pubitemid 37056101)
20. Camparo P., Vasiliu V., Molinie V., et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008 ; 32: 656-670. (Pubitemid 351600831)
21. Geller JI, Dome JS Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004 ; 101: 1575-1583. (Pubitemid 39318904)
22. Geller JI, Argani P., Adeniran A., et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008 ; 112: 1607-1616. (Pubitemid 351441175)
23. Koie T., Yoneyama T., Hashimoto Y., et al. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man. Int J Urol. 2009 ; 16: 333-335.
24. Rais-Bahrami S., Drabick JJ, De Marzo AM, et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology. 2007 ; 70: 178.e3-178.e6.